Drug intelligence / Profile preview

nsaids + sodium citrate + glucosamine

Development stage
Unknown
Lead developer
Seikagaku
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination drug** consisting of: - **Nonsteroidal anti-inflammatory drugs (NSAIDs)**: a class of small molecule drugs that reduce pain and inflammation mainly by inhibiting cyclooxygenase (COX) enzymes, which are involved in prostaglandin synthesis. NSAIDs are commonly used to treat conditions such as **osteoarthritis** and other inflammatory diseases[2][3][1]. - **Sodium citrate**: a salt used as an alkalinizing agent, and in this context may serve to reduce gastrointestinal irritation caused by NSAIDs, although direct supporting evidence for this specific combination is limited. - **Glucosamine (often as sulfate or hydrochloride)**: an amino sugar used primarily as a dietary supplement for osteoarthritis; it is considered to have a chondroprotective effect, possibly by enhancing cartilage repair and reducing joint pain. Recent evidence indicates that glucosamine, especially **glucosamine hydrochloride (GS-HCl)**, may also exert a *synergistic* or *NSAID-sparing effect* by inhibiting the glycosylation of COX-2, and therefore may reduce NSAID-induced gastric damage while maintaining anti-arthritic efficacy[1][2][3][5]. No unique brand or code names are associated with this specific triple combination, but several studies investigate NSAIDs + glucosamine in osteoarthritis (mainly with celecoxib, meloxicam, etoricoxib, ibuprofen, or piroxicam), and combinations are often provided as multi-ingredient supplements or compounded drugs[2][3][1][4].

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on nsaids + sodium citrate + glucosamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nsaids + sodium citrate + glucosamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call